Thanks for requesting our white paper on CAR T-cell therapies: Lessons Learned about Canadian Potential to Navigate Regulatory & Reimbursement Pathway.
New Download - Navigate the Evolving Canadian Cell & Gene Therapy Market

You're viewing an older edition

The latest CRaFT 2026 report has updated reimbursement data, forecasts, and trends. Get the most current insights.

View the 2026 CRaFT Report → Go to homepage